Regional Variation of Care for Irritable Bowel Syndrome in the United States

Share
  • Twitter
  • Facebook
  • email
  • StumbleUpon
  • Delicious
  • Google Reader
  • LinkedIn
  • Google Bookmarks

    P1719 Regional Variation of Care for Irritable Bowel Syndrome in the United States

    Brian E. Lacy, MD, FACG

    Brian E. Lacy, MD, PhD, FACG

    Author insight from Brian E. Lacy, MD,  PhD, FACG, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire

    What’s new here and important for clinicians?

    Although variations in health care have already been analyzed in other disease areas, this study is the first one to analyze variation in care for patients with Irritable Bowel Syndrome (IBS) in the United States (U.S.). Variations in healthcare is a very important topic as it can lead to inappropriate or repeated diagnostic tests and the use of ineffective or unnecessary treatments, which may contribute further to the burden on the health care system. This study found that there is a substantial regional variation of care in the management of IBS across the U.S. Identifying the reasons for these disparities may improve quality of care and reduce the economic burden of IBS.

    What do patients need to know?

    It is important for patients with IBS to understand that the healthcare practices supporting IBS, including the diagnostic procedures and treatments, may vary depending on the geographical location. Patients should maintain an ongoing dialogue with their healthcare providers.

    Read abstract

    Author Contact
    Brian E. Lacy, MD,  PhD, FACG, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
    Brian.E.Lacy@hitchcock.org

    Related Abstracts

    Oral 12 Analysis of Exhaled Volatile Organic Compounds Reveals New Biomarkers for Irritable Bowel Syndrome
    P1718 Age-Related Health Care Disparities in Patients With Irritable Bowel Syndrome: Findings From a Sample of Commercially Insured Patients
    P506 Understanding Gender Differences in IBS: The Role of Stress From the Social Environment
    P1110 Cognitive Behavioral Self-Help for Irritable Bowel Syndrome
    P1117 What Strategies Do Patients With Irritable Bowel Syndrome Continue to Use Following a 9-Week Comprehensive Self-Management Program?
    P1111 Two Years on Linaclotide: Tolerability and Treatment Satisfaction in IBS-C Patients With and Without Diarrhea


    Media Interview Requests:

    To arrange an interview with any ACG experts or abstract authors please contact Jacqueline Gaulin of ACG via email jgaulin@gi.org or by phone at 301-263-9000.

    Share
    • Twitter
    • Facebook
    • email
    • StumbleUpon
    • Delicious
    • Google Reader
    • LinkedIn
    • Google Bookmarks